Results 161 to 170 of about 29,988 (285)

EXPLORING THE THERAPEUTIC POTENTIAL OF FECAL MICROBIOTA TRANSPLANTATION IN INFLAMMATORY BOWEL DISEASE

Agata Mytych, Julia Groszewska, María Albertina Romaniuk, Agata Rapior, Daria Julia Makowska-Woszczyk, Kinga Lubomska, Patrycja Jagura, Jean Gasen Romaniuk, Marta Dziedziak, Łukasz Nosek   +9 more
openalex   +2 more sources

Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD: Interim Results a Non-randomized, Open-label, Phase 1 Clinical Study

, 2020
Ye Zhao, Xuewei Li, Yujing Zhou, Xiao Ma, Feng Chen, Xiaohui Hu, Song Jin, Xuefeng He, Jin Gao, Baoli Zhu, Depei Wu, Xiaofei Qi   +11 more
openalex   +1 more source

Fecal Microbiota Transplantation [PDF]

, 2020
openaire   +1 more source

Dystrophic Skeletal Muscle Phenotypes Can Be Horizontally Transferred via Fecal Microbiome Transplantations

The FASEB Journal, Volume 39, Issue 23, 15 December 2025.
We sought to determine a causal role for the microbiota in promoting dystrophic muscle characteristics by performing intra/inter‐genotype fecal microbiota transplantations (FMT) between wildtype (C57BL/10) and mdx (C57BL/10ScSn‐Dmdmdx/J) mice. We found that transplantation of mdx microbiotas into a wildtype mouse induced an mdx‐like muscle phenotype ...
James Butcher, Jessica T. Gosse, Jonathan Gobin, Aymeric Ravel‐Chapuis, Bernard J. Jasmin, Alain Stintzi   +5 more
wiley   +1 more source

Efficacy of fecal microbiota transplantation in a patient with chronic intractable constipation [PDF]

, 2018
Tadashi Ohara, Tatsuo Suzutani
openalex   +1 more source

Honeysuckle‐Derived Nanovesicles Regulate Gut Microbiota for the Treatment of Inflammatory Bowel Disease

Advanced Science, Volume 12, Issue 45, December 4, 2025.
This study explores honeysuckle‐derived nanovesicles (HNVs) for treating inflammatory bowel disease. Orally administered HNVs alleviates colitis in mice by repairing the gut barrier, reducing inflammation, and restoring a healthy gut microbiota.
Yuanyuan Wang, Yuanhao Zhou, Qingyuan Wu, Yishu Li, Yilin Huang, Kexin Yu, Ping Li, Zhenye Lv, Haotian Liu, Hai Zou, Huiyu Liu, Xiaozhou Mou   +11 more
wiley   +1 more source

Fecal Microbiota Transplantation for Attention-Deficit/Hyperactivity Disorder: Mechanisms, Evidence, and Future Directions. [PDF]

Int J Gen Med
Xiao Y, Wei L, Yu J, Liu Y.
europepmc   +1 more source

Sa1912 Patient Perceptions of Fecal Microbiota Transplantation for Ulcerative Colitis

, 2012
Stacy A. Kahn, A Vachon, Julia A. Marks, Bonnie L. Surma, Dylan M. Rodriquez, Sarah R. Goeppinger, David T. Rubin   +6 more
openalex   +1 more source

Disruption of Gut Microbiota‐Mediated De Novo NAD+ Synthesis Contributes to the Development of Polycystic Ovary Syndrome

Advanced Science, Volume 12, Issue 45, December 4, 2025.
This study demonstrates that patients with PCOS exhibit altered gut microbial profiles, and FMT from PCOS patients induces PCOS‐like symptoms in mice. Specifically, gut dysbiosis reduces 3‐HAA levels in the context of PCOS. Administration of 3‐HAA to mice alleviates PCOS by promoting de novo NAD+ synthesis.
Ke Chen, Huafeng Geng, Yang Zheng, Hongyang Xie, Rui Qin, Junyang Chen, Cong Ye   +6 more
wiley   +1 more source

Fecal Microbiota Transplantation in Refractory Immune-Mediated Colitis: Case Series and Review of the Literature. [PDF]

Pharmaceuticals (Basel)
Golčić M, Radoš L, Skočilić I, Badovinac I, Hauser G, Krznarić Zrnić I, Šantić M, Fučkar Čupić D, Francetić S, Lisica K, Juras L, Škrtić M, Bešvir Džubur A, Šeparović R, Tomašić V, Tečić Vuger A, Mikolašević I.   +16 more
europepmc   +1 more source